Frontiers in Molecular Neuroscience (Sep 2022)

Novel therapeutic modulators of astrocytes for hydrocephalus

  • Yijian Yang,
  • Yijian Yang,
  • Yijian Yang,
  • Yijian Yang,
  • Chuansen Wang,
  • Chuansen Wang,
  • Chuansen Wang,
  • Rui Chen,
  • Yuchang Wang,
  • Yuchang Wang,
  • Yuchang Wang,
  • Changwu Tan,
  • Changwu Tan,
  • Changwu Tan,
  • Jingping Liu,
  • Jingping Liu,
  • Jingping Liu,
  • Qinghua Zhang,
  • Qinghua Zhang,
  • Gelei Xiao,
  • Gelei Xiao,
  • Gelei Xiao

DOI
https://doi.org/10.3389/fnmol.2022.932955
Journal volume & issue
Vol. 15

Abstract

Read online

Hydrocephalus is mainly characterized by excessive production or impaired absorption of cerebrospinal fluid that causes ventricular dilation and intracranial hypertension. Astrocytes are the key response cells to inflammation in the central nervous system. In hydrocephalus, astrocytes are activated and show dual characteristics depending on the period of development of the disease. They can suppress the disease in the early stage and may aggravate it in the late stage. More evidence suggests that therapeutics targeting astrocytes may be promising for hydrocephalus. In this review, based on previous studies, we summarize different forms of hydrocephalus-induced astrocyte reactivity and the corresponding function of these responses in hydrocephalus. We also discuss the therapeutic effects of astrocyte regulation on hydrocephalus in experimental studies.

Keywords